Cannabinoids, neurogenesis and antidepressant drugs: Is there a link?

Current Neuropharmacology

Volumn 11, Issue 3, 2013, Pages 263-275

  Fogaça, Manoela Viar ^a   Galve Roperh, Ismael ^b,c   Guimarães, Francisco Silveira ^a   Campos, Alline Cristina ^d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO RAMÓN Y CAJAL DE INVESTIGACIÓN SANITARIA IRYCIS   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antidepressant drugs; Cannabinoids; Neurogenesis

Indexed keywords

1 (2, 4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2, 4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 4 [6 METHOXY 2 (4 METHOXYPHENYL) 3 BENZOFURANYLCARBONYL] BENZONITRILE; 4 [6 METHOXY 2 (4 METHOXYPHENYL) 3 BENZOFURANYLCARBONYL]BENZONITRILE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL) INDOLE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANTIDEPRESSANT AGENT; CANNABINOID; CANNABINOID 1 RECEPTOR; DESIPRAMINE; DEXANABINOL; ENDOCANNABINOID; FLUOXETINE; IMIPRAMINE; METHANANDAMIDE; MITOGEN ACTIVATED PROTEIN KINASE; MOCLOBEMIDE; N (4 HYDROXYPHENYL) ARACHIDONAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; REBOXETINE; RIMONABANT; SERTRALINE; TIANEPTINE; TRANYLCYPROMINE; UNCLASSIFIED DRUG; VENLAFAXINE;

ANXIETY; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; DENTATE GYRUS; HIPPOCAMPUS; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NONHUMAN; SLEEP DEPRIVATION;

EID: 84878652101     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X11311030003     Document Type: Article

References (145)

1. Aloe, L. Rita Levi-Montalcini: the discovery of nerve growth factor and modern neurobiology. Trends Cell Biol., 2004, 14(7), 395-59.
2. Altman, J. Autoradiographic study of degenerative and regenerative proliferation of neuroglia cells with tritiated thymidine. Exp. Neurol., 1962, 5, 302-18.
3. Altman, J.; Das, G.D. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J. Comp. Neurol., 1965, 124 (3), 319-35.
4. Eriksson, P.S.; Perfilieva, E.; Bjork-Eriksson, T.; Alborn, A.M.; Nordborg, C.; Peterson, D.A.; Gage, F.H. Neurogenesis in the adult human hippocampus. Nat. Med., 1998, 4 (11), 1313-7.
5. Yuan, T.F.; Arias-Carrion, O. Adult neurogenesis in the hypothalamus: evidence, functions, and implications. CNS Neurol. Disord Drug Targets, 2011, 10 (4), 433-9.
6. Lois, C.; Alvarez-Buylla, A. Long distance neuronal migration in the adult mammalian brain. Science, 1994, 264, 1145-1148.
7. Kempermn, G. Adult Neurogenesis: Stem Cells and Neuronal Development in the Adult Brain. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, c2008.
8. Zhao, C.; Deng, W.; Gage, F.H. Mechanisms and functional implications of adult neurogenesis. Cell, 2008, 132 (4), 645-60.
9. Lledo, P.M.; Alonso, M.; Grubb, M.S. Adult neurogenesis and functional plasticity in neuronal circuits. Nat. Rev. Neurosci., 2006, 7 (3), 179-193.
10. Lledo, P.M.; Saghatelyan, A. Integrating new neurons into the adult olfactory bulb: joining the network, life-death decisions, and the effects of sensory experience. Trends Neurosci., 2005, 28 (5), 248-254.
11. Alonso, M.; Viollet, C.; Gabellec, M.M.; Meas-Yedid, V.; Olivo-Marin, J.C.; Lledo, P.M. Olfactory discrimination learning increases the survival of adult-born neurons in the olfactory bulb. J. Neurosci., 2006, 26 (41), 10508-13.
12. Kempermann, G.; Wiskott, L.; Gage, F.H. Functional significance of adult neurogenesis. Curr. Opin. Neurobiol., 2004, 14 (2), 186-191.
13. Abrous, D.N.; Koehl, M.; Le Moal, M. Adult neurogenesis: from precursors to network and physiology. Physiol. Rev., 2005, 85 (2), 523-569.
14. Gould, E.; Beylin, A.; Tanapat, P.; Reeves, A.; Shors, T.J. Learning enhances adult neurogenesis in the hippocampal formation. Nat. Neurosci., 1999, 2 (3), 260-5.
15. Kempermann, G.; Gage, F.H. Genetic influence on phenotypic differentiation in adult hippocampal neurogenesis. Brain Res. Dev. Brain Res, 2002, 134 (1-2), 1-12.
16. Bruel-Jungerman, E.; Laroche, S.; Rampon, C. New neurons in the dentate gyrus are involved in the expression of enhanced long-term memory following environmental enrichment. Eur. J. Neurosci., 2005, 21 (2), 513-521.
17. Coras, R.; Siebzehnrubl, F.A.; Pauli, E.; Huttner, H.B.; Njunting, M.; Kobow, K.; Villmann, C.; Hahnen, E.; Neuhuber, W.; Weigel, D.; Buchfelder, M.; Stefan, H.; Beck, H.; Steindler, D.A.; Blumcke, I. Low proliferation and differentiation capacities of adult hippocampal stem cells correlate with memory dysfunction in humans. Brain, 2010, 133 (11), 3359-72.
18. van Praag, H.; Kempermann, G.; Gage, F.H. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat. Neurosci., 1999, 2 (3), 266-270.
19. Kee, N.J.; Preston, E.; Wojtowicz, J.M. Enhanced neurogenesis after transient global ischemia in the dentate gyrus of the rat. Exp. Brain Res., 2001, 136 (3), 313-320.
20. Tashiro, A.; Makino, H.; Gage, F.H. Experience-specific functional modification of the dentate gyrus through adult neurogenesis: a critical period during an immature stage. J. Neurosci., 2007, 27 (12), 3252-9.
21. Bannerman, D.M.; Rawlins, J.N.; McHugh, S.B.; Deacon, R.M.; Yee, B.K.; Bast, T.; Zhang, W.N.; Pothuizen, H.H.; Feldon, J. Regional dissociations within the hippocampus--memory and anxiety. Neurosci. Biobehav. Rev., 2004, 28 (3), 273-283.
22. Tanapat, P.; Galea, L.A.; Gould, E. Stress inhibits the proliferation of granule cell precursors in the developing dentate gyrus. Int J DevNeurosci, 1998, 16 (3-4), 235-9.
23. Czéh, B.; Michaelis, T.; Watanabe, T.; Frahm, J.; de Biurrun, G.; van Kampen, M.; Bartolomucci, A.; Fuchs, E. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl. Acad. Sci. U. S. A., 2001, 98(22), 12796-2801.
24. Santarelli, L.; Saxe, M.; Gross, C.; Surget, A.; Battaglia, F.; Dulawa, S.; Weisstaub, N.; Lee, J.; Duman, R.; Arancio, O.; Belzung, C.; Hen, R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 2003, 301(5634), 805-9.
25. Petrik, D.; Lagace, D.C.; Eisch, A.J. The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building? Neuropharmacology, 2012, 62 (1), 21-34.
26. Mirescu, C.; Gould, E. Stress and adult neurogenesis. Hippocampus, 2006, 16 (3), 233-8.
27. Snyder, J.S.; Soumier, A.; Brewer, M.; Pickel, J.; Cameron, H.A. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature, 2011, 476 (7361), 458-461
28. Malberg, J.E.; Eisch, A.J.; Nestler, E.J.; Duman, R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci., 2000, 20(24), 9104-10.
29. Kim, J.S.; Chang, M.Y.; Yu, I.T.; Kim, J.H.; Lee, S.H.; Lee, Y.S.; Son, H. Lithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivo. J. Neurochem., 2004, 89 (2), 324-336.
30. David, D.J.; Samuels, B.A.; Rainer, Q.; Wang, J.W.; Marsteller, D.; Mendez, I.; Drew, M.; Craig, D.A.; Guiard, B.P.; Guilloux, J.P.; Artymyshyn, R.P.; Gardier, A.M.; Gerald, C.; Antonijevic, I.A.; Leonardo, E.D.; Hen, R. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron, 2009, 62 (4), 479-493.
31. Axelrod, J. Biogenic amines and their impact in psychiatry. Semin. Psychiatry, 1972, 4 (3), 199-210.
32. Carroll, B.J. Monoamine precursors in the treatment of depression. Clin. Pharmacol. Ther., 1971, 12(5), 743-761.
33. Colonna, L.; Petit M.; Lépine, J.P.; Boismare, F. Depressive states: clinical symptoms and monoaminergic hypothesis. Encephale, 1978, 4(1), 5-17.
34. Charney, D.S.; Menkes, D.B.; Heninger, G.R. Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression. Arch. Gen. Psychiatry, 1981, 38 (10), 1160-80.
35. Checkley, S. Monoamines, depression and antidepressant drugs. Pharmacopsychiatry, 1988, 21 (1), 6-8.
36. Delgado, P.L.; Charney, D.S.; Price, L.H.; Aghajanian, G.K.; Landis, H.; Heninger, G.R. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch. Gen. Psychiatry, 1990, 47 (5), 411-8.
37. Briley, M.; Moret, C. 5-HT and antidepressants: in vitro and in vivo release studies. Trends Pharmacol. Sci., 1993, 14 (11), 396-7.
38. Ngwenya, L.B.; Peters, A.; Rosene, D.L. Maturational sequence of newly generated neurons in the dentate gyrus of the young adult rhesus monkey. J. Comp. Neurol., 2006, 498, 204-216
39. Malberg, J.E.; Duman, R.S. Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology, 2003, 28(9), 1562-71.
40. Airan, R.D.; Meltzer, L.A.; Roy, M.; Gong, Y.; Chen, H., Deisseroth, K. High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science, 2007, 317(5839), 819-823.
41. Surget, A.; Saxe, M.; Leman, S.; Ibarguen-Vargas, Y.; Chalon, S.; Griebel, G.; Hen, R.; Belzung, C. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol Psychiatry, 2008, 64(4), 293-301.
42. Huang, G.J.; Bannerman, D.; Flint, J. Chronic fluoxetine treatment alters behavior, but not adult hippocampal neurogenesis, in BALB/cJmice. Mol. Psychiatry, 2008, 13(2), 119-121.
43. Holick, K.A.; Lee, D.C.; Hen, R.; Dulawa, S.C. Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology, 2008, 33(2), 406-417.
44. Saxe, M.D.; Malleret, G.; Vronskaya, S.; Mendez, I.; Garcia, A.D.; Sofroniew, M.V.; Kandel, E.R.; Hen, R. Paradoxical influence of hippocampal neurogenesis on working memory. Proc. Natl. Acad. Sci. U. S. A., 2007, 104(11), 4642-6.
45. Chen, H.; Pandey, G.N.; Dwivedi, Y. Hippocampal cell proliferation regulation by repeated stress and antidepressants. Neuroreport, 2006, 17(9), 863-7.
46. Ibi, D.; Takuma, K.; Koike, H.; Mizoguchi, H.; Tsuritani, K.; Kuwahara, Y.; Kamei, H.; Nagai, T.; Yoneda, Y.; Nabeshima, T.; Yamada, K. Social isolation rearing-induced impairment of the hippocampal neurogenesis is associated with deficits in spatial memory and emotion-related behaviors in juvenile mice. J. Neurochem., 2008, 105(3), 921-932.
47. Perera, T.D.; Coplan, J.D.; Lisanby, S.H.; Lipira, C.M.; Arif, M.; Carpio, C.; Spitzer, G.; Santarelli, L.; Scharf, B.; Hen, R.; Rosoklija, G.; Sackeim, H.A.; Dwork, A.J. Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J. Neurosci., 2007, 27(18), 4894-4901.
48. Jacobs, B.L.; Tanapat, P.; Reeves, A.J.; Gould, E. Serotonin stimulates the production of new hippocampal granule neurons via the 5-HT1A receptor in the adult rat. Soc. Neurosci. Abstr., 1998, 24, 1992.
49. Radley, J.J.; Jacobs, B.L.5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus. Brain Res., 2002, 955(1-2), 264-7.
50. Xia, L.; Deloménie, C.; David, I.; Rainer, Q.; Marouard, M.; Delacroix, H.; David, D.J.; Gardier, A.M.; Guilloux, J.P. Ventral hippocampal molecular pathways and impaired neurogenesis associated with 5-HT(1A) and 5-HT(1B) receptors disruption in mice. Neurosci. Lett., 2012, 521(1), 20-5.
51. Masuda, T.; Nakagawa, S.; Boku, S.; Nishikawa, H.; Takamura N., Kato, A.; Inoue, T.; Koyama, T. Noradrenaline increases neural precursor cells derived from adult rat dentate gyrus through beta2 receptor. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2012, 36(1), 44-5.
52. Jhaveri, D.J.; Mackay, E.W.; Hamlin, A.S.; Marathe, S.V.; Nandam, L.S.; Vaidya VA, Bartlett, PF. Norepinephrinedirectlyactivatesadulthippocampalprecursors via beta3-adrenergic receptors. J. Neurosci., 2010, 30(7), 2795-2806.
53. Sairanen, M.; Lucas, G.; Ernfors, P.; Castrén, M.; Castrén, E. Brainderived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J. Neurosci., 2005, 25(5), 1089-1094.
54. Warner-Schmidt, J.L.; Duman, R.S. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc. Natl. Acad. Sci. U. S. A., 2007, 104(11), 4647-4652.
55. Duman, R.S.; Nakagawa, S.; Malberg, J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology, 2001, 25(6), 836-44.
56. Pinnock, S.B.; Blake, A.M.; Platt, N.J.; Herbert, J. The roles of BDNF, pCREB and Wnt3a in the latent period preceding activation of progenitor cell mitosis in the adult dentate gyrus by fluoxetine. PLoS One, 2010, 5(10), e13652.
57. Pechnick, R.N.; Zonis, S.; Wawrowsky, K.; Cosgayon, R.; Farrokhi, C.; Lacayo, L.; Chesnokova, V. Antidepressants stimulate hippocampal neurogenesis by inhibiting p21 expression in the subgranular zone of the hipppocampus. PLoS One, 2011, 6(11), e27290.
58. Gaoni, Y.; Mechoulam, R. The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish. J. Am. Chem. Soc., 1971, 93(1), 217-24.
59. Mechoulam, R.; Braun, P.; Gaoni, Y. Syntheses of 1 -tetrahydrocannabinol and related cannabinoids. J. Am. Chem. Soc., 1972, 94(17), 6159-6165.
60. Pertwee, R.G. Cannabinoid pharmacology: the first 66 years. Br. J.Pharmacol., 2006, v. 147 Suppl 1, S163-71.
61. Pertwee, R.G.; Howlett, A.C.; Abood, M.E.; Alexander, S.P.; Di Marzo, V.; Elphick, M.R.; Greasley, P.J.; Hansen, H.S.; Kunos, G.; Mackie, K.; Mechoulam, R.; Ross, R.A. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol. Rev., 2010, v. 62(4), 588-631.
62. Mechoulam, R.; Lander, N.; Varkony, T.H.; Kimmel, I.; Becker, O.; Ben-Zvi, Z.; Edery, H.; Porath, G. Stereochemical requirements for cannabinoid activity.J. Med. Chem., 1980, 23(10), 1068-1072.
63. Little, P.J.; Compton, D.R.; Johnson, M.R.; Melvin, L.S.; Martin, B.R. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J. Pharmacol. Exp. Ther., 1998, v. 247(3), 1046:1051.
64. Howlett, A.C.; Qualy, J.M.; Khachatrian, L.L. Involvement of Gi in the inhibition of adenylatecyclase by cannabimimetic drugs. Mol.Pharmacol., 1986, v. 29(3):307-313.
65. Glass, M.; Northup, J.K. Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors. Mol.Pharmacol., 1999, v 56(6), 1362-2369.
66. Howlett, A.C.; Barth, F.; Bonner, T.I.; Cabral, G.; Casellas, P.; Devane, W.A.; Felder, C.C.; Herkenham, M.; Mackie, K.; Martin, B.R.; Mechoulam, R.; Pertwee, R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 2002, 54(2), 161-202.
67. Gómez-Ruiz, M.; Hernández, M.; de Miguel, R.; Ramos, J.A. An overview on the biochemistry of the cannabinoid system. Mol. Neurobiol., 2007, 36, 3-14.
68. Brusco, A.; Tagliaferro, P.; Saez, T.; Onaivi, E.S. Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse, 2008, 62(12), 944-9.
69. Moldrich, G.; Wenger, T. Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study. Peptides, 2000, 21(11), 1735-1742.
70. Eggan, S.M.; Lewis, D.A. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb. Cortex, 2007, v. 17(1), 175-91.
71. Micale, V.; Cristino, L.; Tamburella, A.; Petrosino, S.; Leggio, G.M.; Drago, F.; Di Marzo, V. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Neuropsychopharmacology, 2009, v. 34(3), 593-606.
72. Gong, J.P.; Onaivi, E.S.; Ishiguro, H.; Liu, Q.R.; Tagliaferro, P.A.; Brusco, A.; Uhl, G.R. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 2006, 1071(1), 10-23.
73. Onaivi, E.S. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology, 2006, 54(4), 231-246.
74. Piomelli, D. The endocannabinoid system: a drug discovery perspective. Curr. Opin. Investig. Drugs, 2005, 6(7), 672-9.
75. Zuardi, A.W.; Rodrigues, J.A.; Cunha, J.M. Effects of cannabidiol in animal models predictive of antipsychotic activity. Psychopharmacology (Berl), 1991, 104(2), 260-4.
76. Zanelati, T.V.; Biojone, C.; Moreira, F.A.; Guimarães, F.S.; Joca, S.R. Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. Br. J. Pharmacol., 2010, 159(1), 122-8.
77. Guimarães, F.S.; Chiaretti, T.M.; Graeff, F.G.; Zuardi, A.W. Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology (Berl), 1990, 100(4), 558-9.
78. Moreira, F.A.; Aguiar, D.C.; Guimarães, F.S. Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2006, 30(8), 1466-1471.
79. Moreira, F.A.; Aguiar, D.C.; Guimarães, F.S. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaquidutal gray. Neuropharmacology, 2007, 52, 958-965.
80. Bergamaschi, M.M.; Queiroz, R.H.; Chagas, M.H.; de Oliveira D.C.; De Martinis, B.S.; Kapczinski, F.; Quevedo, J.; Roeslerm R.; Schröder, N.; Nardi, A.E.; Martín-Santosm R.; Hallak, J.E.; Zuardi, A.W.; Crippa, J.A. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology, 2011, 36, 1219-1226.
81. Szabo, B.; Schlicker, E. Effects of cannabinoids on neurotransmission. Handb. Exp. Pharmacol., 2005, 168, 327-165.
82. Diana, M.A.; Marty, A. Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br. J. Pharmacol., 2004, 142(1), 9-19.
83. Yoshida, T.; Hashimoto, K.; Zimmer, A.; Maejima, T.; Araishi, K.; Kano, M. The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells. J.Neurosci., 2002, 22(5), 1690-7.
84. Ohno-Shosaku, T.; Tsubokawa H.; Mizushima, I.; Yoneda, N; Zimmer, A.; Kano, M. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J. Neurosci., 2002, 22(10), 3864-3872.
85. Narushima, M.; Uchigashima, M.; Hashimoto, K.; Watanabe, M.; Kano, M. Depolarization-induced suppression of inhibition mediated by endocannabinoids at synapses from fast-spiking interneurons to medium spiny neurons in the striatum. Eur. J. Neurosci., 2006, 24(8), 2246-2252.
86. Zoppi, S.; Pérez Nievas, B.G.; Madrigal, J.L.; Manzanares, J.; Leza, J.C.; García-Bueno, B. Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. Neuropsychopharmacology, 2011, 36(4), 805-18.
87. Marsicano, G.; Goodenough, S.; Monory, K.; Hermann, H.; Eder M.; Cannich, A.; Azad, S.C.; Cascio, M.G.; Gutiérrez, S.O.; van der Stelt, M.; López-Rodriguez, M.L.; Casanova, E.; Schütz, G.; Zieglgänsberger, W.; Di Marzo, V.; Behl, C.; Lutz, B. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science, 2003, 302(5642), 84-8.
88. Shen, M.; Thayer, S.A. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol. Pharmacol., 1998, 54(3), 459-62.
89. Harkany, T.; Guzmán, M.; Galve-Roperh, I.; Berghuis, P.; Devi, L.A.; Mackie, K. The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol. Sci., 2007, 28(2), 83-92.
90. Aguado, T.; Monory, K.; Palazuelos, J.; Stella, N.; Cravatt, B.; Lutz, B.; Marsicano, G.; Kokaia, Z.; Guzmán, M.; Galve-Roperh, I. The endocannabinoid system drives neural progenitor proliferation. FASEB J., 2005, 19(12), 1704-6.
91. Palazuelos, J.; Aguado, T.; Egia, A.; Mechoulam, R.; Guzman, M.; Galve-Roperh, I. Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation. FASEB J, 2006, 20 (13), 2405-7.
92. Jiang, S.; Fu, Y.; Williams, J.; Wood, J.; Pandarinathan, L.; Avraham, S.; Makriyannis, A.; Avraham, S.; Avraham, H.K. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells. PLoSOne, 2007, 2(7), e641.
93. Aguado, T.; Romero, E.; Monory, K.; Palazuelos, J.; Sendtner, M.; Marsicano, G.; Lutz, B.; Guzmán, M.; Galve-Roperh, I. The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis. J. Biol. Chem., 2007, 282(33), 23892-8.
94. Goncalves, M.B.; Suetterlin, P.; Yip, P.; Molina-Holgado, F.; Walker, D.J.; Oudin, M.J.; Zentar, M.P.; Pollard, S.; Yáñez-Muñoz, R.J.; Williams, G.; Walsh, F.S.; Pangalos, M.N.; Doherty, P. A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner. Mol. Cell. Neurosci., 2008, 38(4), 526-36.
95. Palazuelos, J.; Ortega, Z.; Díaz-Alonso, J.; Guzmán, M.; Galve-Roperh, I. CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling.J. Biol. Chem., 2012, 287(2), 1198-11209.
96. Marchalant, Y.; Brothers, H.M.; Wenk, G.L. Cannabinoid agonist WIN-55, 212-2 partially restores neurogenesis in the aged rat brain. Mol. Psychiatry, 2009, 14(12), 1068-9.
97. Hill, M.N.; Kambo, J.S.; Sun, J.C.; Gorzalka, B.B.; Galea, L.A. Endocannabinoids modulate stress-induced suppression of hippocampal cell proliferation and activation of defensive behaviours. Eur. J. Neurosci., 2006, 24(7), 1845-9.
98. Esposito, G.; Scuderi, C.; Valenza, M.; Togna, G.I.; Latina, V.; De Filippis, D.; Cipriano, M.; Carratù, M.R.; Iuvone, T.; Steardo, L. Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement. PLoS One, 2011, 6(12), e28668.
99. Wolf, S.A.; Bick-Sander, A.; Fabel, K.; Leal-Galicia, P.; Tauber, S.; Ramirez-Rodriguez, G.; Müller, A.; Melnik, A.; Waltinger, T.P.; Ullrich, O.; Kempermann, G. Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis. Cell. Commun. Signal, 2010, 8, 12.
100. Campos, A.C.; Ortega, Z.; Palazuelos, J.; Fogaca, M.V.; Aguiar, D.C.; Díaz-Alonso, J.; Ortega-Gutierrez, S.; Vazquez-Villa, H.; Moreira, F.A.; Guzman, M; Galve-Roperh, I.; Guimarães, F. S. The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system. Intl. J. Neuropsychopharmacol., 2013 (In press).
101. Han, J.; Kesner, P.; Metna-Laurent, M.; Duan, T.; Xu, L.; Georges, F.; Koehl, M.; Abrous, D. N.; Mendizabal-Zubiaga, J.; Grandes, P.; Liu, Q.; Bai, G.; Wang, W.; Xiong, L.; Ren, W.; Marsicano, G.; Zhang, X. Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell, 2012, 148(5), 1039-1050.
102. Lee, S.; Kim, D.H.; Yoon, S.H.; Ryu, J.H. Sub-chronic administration of rimonabant causes loss of antidepressive activity and decreases doublecortinimmunoreactivity in the mouse hippocampus. Neurosci. Lett., 2009, 467(2), 111-6.
103. Jin, K.; Xie, L.; Kim, S.H.; Parmentier-Batteur, S.; Sun, Y.; Mao, X.O.; Childs, J.; Greenberg, D.A. Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol. Pharmacol., 2004, 66(2), 204-8.
104. Vaughn, L.K.; Denning, G.; Stuhr, K.L.; de Wit, H.; Hill, M.N.; Hillard, C.J. Endocannabinoidsignalling: has it got rhythm? Br. J. Pharmacol., 2010, 160 (3), 530-43.
105. Chen, C.; Bazan, N.G. Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons. J. Neurophysiol., 2005, 93 (2), 929-41.
106. Hill, M.N.; Barr, A.M.; Ho, W.S.; Carrier, E.J.; Gorzalka, B.B.; Hillard, C.J. Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity. J. Neurochem., 2007, 103 (1), 47-56.
107. Hill, M.N.; Ho, W.S.; Sinopoli, K.J.; Viau, V.; Hillard, C.J.; Gorzalka, B.B. Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology, 2006, 31 (12), 2591-9.
108. Hill, M.N.; Carrier, E.J.; McLaughlin, R.J.; Morrish, A.C.; Meier, S.E.; Hillard, C.J.; Gorzalka, B.B. Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. J. Neurochem., 2008, 106 (6), 2322-2336.
109. Hill, M.N.; Patel, S.; Carrier, E.J.; Rademacher, D.J.; Ormerod, B.K.; Hillard, C.J.; Gorzalka, B.B. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology, 2005, 30 (3), 508-15.
110. Hill, M.N.; Ho, W.S.; Hillard, C.J.; Gorzalka, B.B. Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents. J. Neural. Transm., 2008, 115 (12), 1673-9.
111. Mato, S.; Vidal, R.; Castro, E.; Diaz, A.; Pazos, A.; Valdizan, E.M. Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine 1A receptordependent mechanisms. Mol. Pharmacol., 2010, 77 (3), 424-34.
112. Hesketh, S.A.; Brennan, A.K.; Jessop, D.S.; Finn, D.P. Effects of chronic treatment with citalopram on cannabinoid and opioid receptor-mediated G-protein coupling in discrete rat brain regions. Psychopharmacology (Berl), 2008, 198 (1), 29-36.
113. Kleijn, J.; Cremers, T.I.; Hofland, C.M.; Westerink, B.H. CB-1 receptors modulate the effect of the selective serotonin reuptake inhibitor, citalopram on extracellular serotonin levels in the rat prefrontal cortex. Neurosci. Res., 2011, 70 (3), 334-7.
114. Bambico, F.R.; Nguyen, N.T.; Katz, N.; Gobbi, G. Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission. Neurobiol. Dis., 2010, 37 (3), 641-55.
115. Cassano, T.; Gaetani, S.; Macheda, T.; Laconca, L.; Romano, A.; Morgese, M.G.; Cimmino, C.S.; Chiarotti, F.; Bambico, F.R.; Gobbi, G.; Cuomo, V.; Piomelli, D. Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice. Psychopharmacology (Berl), 2011, 214 (2), 465-76.
116. Bambico, F.R.; Cassano, T.; Dominguez-Lopez, S.; Katz, N.; Walker, C.D.; Piomelli, D.; Gobbi, G. Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus. Neuropsychopharmacology, 2010, 35 (10), 2083-2100.
117. Mato, S.; Aso, E.; Castro, E.; Martin, M.; Valverde, O.; Maldonado, R.; Pazos, A. CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors. J. Neurochem., 2007, 103 (5), 2111-2120.
118. Steiner, M.A.; Marsicano, G.; Nestler, E.J.; Holsboer, F.; Lutz, B.; Wotjak, C.T. Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. Psychoneuroendocrinology, 2008, 33 (1), 54-67.
119. Aso, E.; Renoir, T.; Mengod, G.; Ledent, C.; Hamon, M.; Maldonado, R.; Lanfumey, L.; Valverde, O. Lack of CB1 receptor activity impairs serotonergic negative feedback. J. Neurochem., 2009, 109 (3), 935-44.
120. Boldrini, M.; Underwood, M.D.; Hen, R.; Rosoklija, G.B.; Dwork, A.J.; John, M.J.; Arango, V. Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology, 2009, 34 (11), 2376-2389.
121. Malberg, J.E.; Blendy, J.A. Antidepressant action: to the nucleus and beyond. Trends Pharmacol. Sci., 2005, 26 (12), 631-8.
122. Musazzi, L.; Mallei, A.; Tardito, D.; Gruber, S.H.; El Khoury, A.; Racagni, G.; Mathe, A.A.; Popoli, M. Early-life stress and antidepressant treatment involve synaptic signaling and Erk kinases in a gene-environment model of depression. J. Psychiatr. Res., 2010, 44 (8), 511-20.
123. Galve-Roperh, I.; Rueda, D.; Gomez del Pulgar, T.; Velasco, G.; Guzman, M. Mechanism of extracellular signal-regulated kinase activation by the CB(1) cannabinoid receptor. Mol. Pharmacol., 2002, 62 (6), 1385-1392.
124. Aydemir, O.; Deveci, A.; Taskin, O.E.; Taneli, F.; Esen-Danaci, A. Serum brain-derived neurotrophic factor level in dysthymia: a comparative study with major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2007, 31 (5), 1023-6.
125. Chen, B.; Dowlatshahi, D.; MacQueen, G.M.; Wang, J.F.; Young, L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry, 2001, 50 (4), 260-5.
126. Blazquez, C.; Chiarlone, A.; Sagredo, O.; Aguado, T.; Pazos, M.R.; Resel, E.; Palazuelos, J.; Julien, B.; Salazar, M.; Borner, C.; Benito, C.; Carrasco, C.; Diez-Zaera, M.; Paoletti, P.; Diaz-Hernandez, M.; Ruiz, C.; Sendtner, M.; Lucas, J.J.; de Yebenes, J.G.; Marsicano, G.; Monory, K.; Lutz, B.; Romero, J.; Alberch, J.; Gines, S.; Kraus, J.; Fernandez-Ruiz, J.; Galve-Roperh, I.; Guzman, M. Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease. Brain, 2011, 134 (Pt 1), 119-36.
127. Elbatsh, M.M.; Moklas, M.A.; Marsden, C.A.; Kendall, D.A. Antidepressant-like effects of Delta(9)-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression. Pharmacol. Biochem. Behav, 2012, 102 (2), 357-65.
128. Schmidt, H.D.; Duman, R.S. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav. Pharmacol., 2007, 18 (5-6), 391-418.
129. Huang, E.J.; Reichardt, L.F. Trk receptors: roles in neuronal signal transduction.Annu. Rev. Biochem., 2003, 72, 609-42.
130. Mostany, R.; Valdizan, E.M.; Pazos, A. A role for nuclear betacatenin in SNRI antidepressant-induced hippocampal cell proliferation. Neuropharmacology, 2008, 55 (1), 18-26.
131. Kodama, M.; Fujioka, T.; Duman, R. S. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol. Psychiatry, 2004, 56(8), 570-80.
132. Su, X.W.; Li, X. Y.; Banasr, M.; Duman, R. S. Eszopiclone and fluoxetine enhance the survival of newborn neurons in the adult rat hippocampus. Int. J. Neuropsychopharmacol., 2009, 12(10), 1421-8.
133. Wu, X.; Castrén, E. Co-treatment with diazepam prevents the effects of fluoxetine on the proliferation and survival of hippocampal dentate granule cells. Biol. Psychiatry, 2009, 66(1), 5-8.
134. Marcussen, A. B.; Flagstad, P.; Kristjansen, P. E.; Johansen, F. F.; Englund, U. Increase in neurogenesis and behavioural benefit after chronic fluoxetine treatment in Wistar rats. Acta Neurol.Scand., 2008, 117(2), 94-100.
135. Ibi, D.; Takuma, K.; Koike, H.; Mizoguchi, H.; Tsuritani, K.; Kuwahara, Y.; Kamei, H.; Nagai, T.; Yoneda, Y.; Nabeshima, T.; Yamada, K. Social isolation rearing-induced impairment of the hippocampal neurogenesis is associated with deficits in spatial memory and emotion-related behaviors in juvenile mice. J. Neurochem., 2008, 105(3), 921-32.
136. Khawaja, X.; Xu, J.; Liang, J. J.; Barrett, J. E.Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies. J. Neurosci. Res., 2004, 75(4), 451-60.
137. Bessa, J. M.; Ferreira, D.; Melo, I.; Marques, F.; Cerqueira, J. J.; Palha, J. A.; Almeida, O. F.; Sousa, N. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol. Psychiatry, 2009, 14(8), 764-773, 739.
138. Wang, J. W.; David, D. J.; Monckton, J. E.; Battaglia, F.; Hen, R. Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J. Neurosci., 2008, 28(6), 1374-1384.
139. Hitoshi, S.; Maruta, N.; Higashi, M.; Kumar, A.; Kato, N.; Ikenaka, K. Antidepressant drugs reverse the loss of adult neural stem cells following chronic stress. J. Neurosci. Res., 2007, 85(16), 3574-3585.
140. Li, Y. F.; Zhang, Y. Z.; Liu, Y. Q.; Wang, H. L.; Yuan, L.; Luo, Z. P. Moclobemide up-regulates proliferation of hippocampal progenitor cells in chronically stressed mice. Acta Pharmacol Sin., 2004, 25(11):1408-1412.
141. Anacker, C.; Zunszain, P. A.; Cattaneo, A.; Carvalho, L. A.; Garabedian, M. J.; Thuret, S.; Price, J.; Pariante, C. M. Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Mol. Psychiatry, 2011, 16(7), 738-50.
142. Rueda, D.; Navarro, B.; Martinez-Serrano, A.; Guzman, M.; Galve-Roperh, I. The endocannabinoidanandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/BRaf/ ERK pathway. J. Biol. Chem., 2002, 29, 277(48), 46645-46650.
143. Kochman, L. J.; dos Santos, A. A.; Fornal, C. A.; Jacobs, B. L. Despite strong behavioral disruption, Delta9-tetrahydrocannabinol does not affect cell proliferation in the adult mouse dentate gyrus. Brain Res., 2006, 1113(1), 86-93.
144. Hill, M. N.; Titterness, A. K.; Morrish, A. C.; Carrier, E. J.; Lee, T. T.; Gil-Mohapel, J.; Gorzalka, B. B.; Hillard, C.J.; Christie, B. R. Endogenous cannabinoid signaling is required for voluntary exercise-induced enhancement of progenitor cell proliferation in the hippocampus. Hippocampus, 2010, 20(4), 513-23.
145. Chen, F.; Madsen, T. M.; Wegener, G.; Nyengaard, J. R. Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression. Hippocampus, 2010, 20(12), 1376-1384.